Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The New York Proton Center
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Biopsy-proven NCCN low- or intermediate-risk prostate cancer, which includes patients with:
Gleason score ≤7 disease
PSA ≤20 ng/ml
Clinical T1-T2c disease
* Note: Patients who only have radiographic evidence of possible or probable T3 disease (i.e., extracapsular extension or seminal vesical invasion) will not be excluded.
KPS ≥ 80%
Prostate size as determined on MRI to be \< 100 cc. Prostate size can be determined on CT scan if MRI is not available.
Male 18 years of age or older
IPSS ≤ 20
Patient must be a candidate for and agree to placement of intraprostatic fiducial markers and a hydrogel rectal spacer
Patient must be available for at least 2 years of follow-up
Prior history of chronic prostatitis or urethral stricture
Currently active cancer(s) other than non-melanoma skin cancers. Patients are not considered to have currently active cancers if they have completed therapy and are considered by their physicians to be at \<5% risk of relapse within 2 years.
Life expectancy of \< 2 years
You may not be if
Prior prostate surgery (including cryosurgery)
Clareo Health | Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer
